Inhibition of the de-myelinating properties of Aicardi-Goutières Syndrome lymphocytes by cathepsin D silencing

Biochemical and Biophysical Research Communications

Volumn 430, Issue 3, 2013, Pages 957-962

  Pulliero, A ^a   Marengo, B ^a   Longobardi, M ^a   Fazzi, E ^b   Orcesi, S ^c   Olivieri, I ^c   Cereda, C ^c   Domenicotti, C ^a   Balottin, U ^c,d   Izzotti, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

Aicardi Gouti res Syndrome; Cathepsin D; De myelination; Interferon alpha; Lymphocytes; RNA interference

Indexed keywords

ALPHA INTERFERON; CATHEPSIN D;

AICARDI GOUTIERES SYNDROME; ARTICLE; ASTROCYTE; CELL IMMORTALIZATION; COCULTURE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE CULTURE; MICROSCOPY; NEUROTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ASTROCYTES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CATHEPSIN D; CELL LINE, TUMOR; HUMANS; INTERFERON-ALPHA; LYMPHOCYTES; NERVE TISSUE PROTEINS; NERVOUS SYSTEM MALFORMATIONS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84872497530     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.131     Document Type: Article

References (30)

1. Izzotti A., Pulliero A., Orcesi S., et al. Interferon-related transcriptome alterations in the cerebrospinal fluid cells of Aicardi-Goutières patients. Brain Pathol. 2009, 19:650-660.
2. Izzotti A., Fazzi E., Orcesi S., et al. Brain damage as detected by cDNA-microarray in the spinal fluid of patients with Aicardi- Goutières syndrome. Neurology 2008, 71:610-612.
3. Izzotti A., Longobardi M., Cartiglia C., et al. Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in Aicardi-Goutieres Syndrome. J. Child Neurol. 2012, 27:51-60.
4. Pulliero A., Marengo B., Domenicotti C., et al. Inhibition of neuroblastoma cell growth by TREX1-mutated human lymphocytes. Oncol. Rep. 2012, 27:1689-1694.
5. de la Fuente H., Richaud-Patin Y., Jakez-Ocampo J., et al. Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE). Immunol. Lett. 2001, 77:175-180.
6. Kim S.J., Kim K.H., Ahn E.R., et al. Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival. Amino Acids 2011, , http://dx.doi.org/10.1007/s00726-011-1089-6.
7. Hewitt E.W., Treumann A., Morrice N., et al. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation. Immunology 1997, 87:83-87.
8. Rintahaka J., Lietzén N., öhman T., et al. Recognition of cytoplasmic RNA results in cathepsin-dependent inflammasome activation and apoptosis in human macrophages. Immunology 2011, 186:3085-3092.
9. Pulliero A., Fazzi E., Cartiglia C., et al. The Aicardi-Goutières Syndrome. Molecular and clinical features of RNAse deficiency and microRNA overload. Mutat. Res. 2011, 717:99-108.
10. Ma J., Tanaka K.F., Yamada G., et al. Induced expression of cathepsins and cystatin C in a murine model of demyelination. Neurochem. Res. 2007, 32:311-320.
11. Ferrera F., Hahn B.H., Rizzi M., et al. Protection against renal disease in (NZB x NZW) F (1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. Arthritis Rheum. 2007, 56:1945-1953.
12. P.D. Ling, H.M. Huls, Isolation and immortalization of lymphocytes, Curr. Protoc. Mol. Biol. 28 (2005), http://dx.doi.org/10.1002/0471142727.mb2802s70.
13. Fazzi E., Cattalini M., Orcesi S., et al. a rare neurological disease in children: A new autoimmune disorder?. Autoimmun. Rev. 2012, [Epub ahead of print].
14. Huber-Lang M., Denk S., Fulda S., et al. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro. Mol. Immunol. 2012, 50:60-65.
15. Rodriguez-Franco E.J., Cantres-Rosario Y.M., Plaud-Valentin M., et al. Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis. PLoS One 2012, 7:e36571.
16. Crow Y.J., Hayward B.E., Parmar R., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres Syndrome at the AGS1 locus. Nat. Genet. 2006, 38:917-920.
17. Crow Y.J., Leitch A., Hayward B.E., et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres Syndrome and mimic congenital viral brain infection. Nat. Genet. 2006, 38:910-916.
18. Rice G.I., Kasher P.R., Forte G.M., et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat. Genet. 2012, 44:1243-1248.
19. Gall A., Treuting P., Elkon K.B., et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012, 36:120-131.
20. Tizon B., Sahoo S., Yu H., et al. Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One 2010, 23:e9819.
21. Lenarcic B., Kos J., Dolenc I., et al. Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. Biochem. Biophys. Res. Commun. 1988, 154:765-772.
22. Ma J., Tanaka K.F., Shimizu T., et al. Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination. J. Neurosci. Res. 2011, 89:639-649.
23. Kroemer G., Martin S.J. Caspase-independent cell death. Nat. Med. 2005, 11:725-730.
24. Lajoie P., Guay G., Dennis J.W., et al. The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies. J. Cell Sci. 2005, 118:1991-2003.
25. Hah Y.S., Noh H.S., Ha J.H., et al. Cathepsin D inhibits oxidative stress-induced cell death via activation of autophagy in cancer cells. Cancer Lett. 2012, 323:208-214.
26. Zhou W., Scott S.A., Shelton S.B., et al. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease. Neuroscience 2006, 143:689-701.
27. Kim S., Ock J., Kim A.K., et al. Neurotoxicity of microglial cathepsin D revealed by secretome analysis. J. Neurochem. 2007, 103:2640-2650.
28. Beck-Engeser G.B., Eilat D., Wabl M. An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 2011, 8:91.
29. Stetson D.B., Ko J.S., Heidmann T., et al. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
30. Coca A., Sanz I. Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome. Curr. Opin. Rheumatol. 2012, 24:451-456.